Overweight and Obesity in Children: More Than Just the Kilos

Edgar van Mil1, Arianne Struik

  • 1Department of Pediatrics (Dr van Mil), Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands; and Institute for Chronically Traumatized Children (Ms Struik), Perth, Australia.

Insights

This study introduces a new model for childhood obesity treatment, empowering families through psycho-education and support networks. The approach enhances children's autonomy and self-management skills for sustained healthy lifestyles.

Area of Science:

  • Pediatrics
  • Childhood Obesity Research
  • Health Psychology

Background:

  • Childhood obesity is a significant public health concern requiring innovative treatment models.
  • Existing approaches may not adequately engage families or foster long-term adherence.
  • A multidisciplinary, network-based approach is needed to address the complexities of pediatric overweight.

Purpose of the Study:

  • To implement and evaluate a novel diagnostic and treatment model for overweight children.
  • To enhance family engagement and children's self-management skills in obesity care.
  • To explore the impact of psycho-education and social support on treatment adherence.

Main Methods:

  • A hospital-based model integrated into a broader cure and care network.
  • Psycho-education tailored to a 6-year-old's comprehension level for parents and children.
  • Utilization of family workbooks and worksheets to foster autonomy and motivation.
  • Collaboration with the family's existing support network.

Main Results:

  • Increased autonomy, competence, and connectedness in participating children and parents.
  • Enhanced understanding and informed decision-making regarding health behaviors.
  • Strengthened family support systems and reduced feelings of isolation.
  • Improved motivation for sustained participation in the treatment network.

Conclusions:

  • The new model effectively promotes healthier lifestyles in overweight children by addressing core motivational needs.
  • Psycho-education and integrated support networks are crucial for empowering families in obesity management.
  • This approach fosters self-management skills and long-term adherence to treatment plans.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
315
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
324
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
250
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.1K
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
874